Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The answer from PTSC to the USPTO contingency is .....

I can't see where a cross-licensing agreement does anything for PTSC. TPL, maybe yes. PTSC, no. If it is ever determined that this was the grand "Business Resolution", PTSC should sue TPL for breech of contract (Master Agreement), IMVHO.

SGE

Share
New Message
Please login to post a reply